Marked difference in pathophysiology between tissue factor- and lipopolysaccharide-induced disseminated intravascular coagulation models in rats
- 1 January 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 30 (1), 161-164
- https://doi.org/10.1097/00003246-200201000-00023
Abstract
Tissue factor and lipopolysaccharide frequently have been used to induce disseminated intravascular coagulation in experimental animal models. Although the pathophysiology of disseminated intravascular coagulation may differ according to the agents used to induce it, these previous models have not distinguished between the use of different disseminated intravascular coagulation-inducing agents. In this study, we attempted to evaluate the characteristic features of these agents in two types of disseminated intravascular coagulation models, with special reference to selected hemostatic parameters and pathologic findings in the kidney. Prospective, comparative, experimental study. Laboratory at a university hospital. Twenty-seven male Wistar rats, age 6–7 wks, weighing 160–170 g. Three groups of animals were studied: a control group (n = 8) receiving physiologic saline, a tissue factor-treated group (n = 11) receiving tissue factor 3.75 units/kg, and a lipopolysaccharide-treated group (n = 8) receiving lipopolysaccharide 30 mg/kg; each group sustained infusion for 4 hrs via the tail vein. The degree of hemostatic activation in both types of experimental disseminated intravascular coagulation was identical, based on the results of thrombin-antithrombin III complex levels. Markedly elevated D-dimer concentrations were observed without organ dysfunction or fibrin deposition in the kidney on administration of tissue factor, whereas markedly elevated plasminogen activator inhibitor activity, decreased antithrombin III activity, severe organ failure, and marked fibrin deposition in the kidney were observed for lipopolysaccharide administration. Because pathophysiology differed remarkably between the tissue factor- and lipopolysaccharide-induced disseminated intravascular coagulation models in rats, we recommend that they be assessed carefully as distinct entities to determine implications of their experimental and clinical use.Keywords
This publication has 15 references indexed in Scilit:
- Lepirudin blunts endotoxin-induced coagulation activationBlood, 2000
- Disseminated Intravascular CoagulationThrombosis and Haemostasis, 1999
- Plasminogen Activator and Plasminogen Activator Inhibitor I Release during Experimental Endotoxaemia in Chimpanzees: Effect of Interventions in the Cytokine and Coagulation CascadesClinical Science, 1995
- Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markersBlood Coagulation & Fibrinolysis, 1994
- Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees.The Journal of Experimental Medicine, 1994
- Activation of Coagulation after Administration of Tumor Necrosis Factor to Normal SubjectsNew England Journal of Medicine, 1990
- Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activityBlood, 1990
- Thrombin Vs. Plasmin generation in disseminated lntravascular coagulation associated with various underlying disordersAmerican Journal of Hematology, 1990
- Promotion and Subsequent Inhibition of Plasminogen Activation after Administration of Intravenous Endotoxin to Normal SubjectsNew England Journal of Medicine, 1989
- Potential role of interleukin-1 as the trigger for diffuse intravascular coagulation in acute nonlymphoblastic leukemiaAmerican Journal Of Medicine, 1988